Later this month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies.
Torrey Pines Institute for Molecular Studies (TPIMS), a non-profit research institution and leader in advanced methods of drug discovery, and InvivoSciences Inc., an innovative company providing screening for first-in-class drug discovery, announced today a new collaboration to accelerate drug discovery in cardiac disease. Under the terms of the agreement, Torrey Pines Institute will work with InvivoSciences to screen the…
Read more
As a leading provider of 3D, ready-to-use human engineered tissues, Madison-based InvivoSciences has products and capabilities that are of interest to a global audience. Reaching that audience is one of the many reasons Wisconsin biotechnology leaders and company representatives made their way to Boston in June for the 20th annual BIO International Convention. Their presence was…
Read more
InvivoSciences, LLC (IVS) and Myomics, Inc. (Providence, RI) announce a corporate partnership to provide high content compound screening services using 3D engineered tissue. Both Myomics and IVS have pioneered and perfected their technologies to mass-produce and assay miniaturized engineered human and animal tissues in standardized 96- and 384- well formats. Using their combined rich portfolio…
Read more
Recent Comments